2022
DOI: 10.1016/j.jsps.2022.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Real-world pharmacological treatment of patients with postpartum depression in China from 2016 to 2020: A cross-sectional analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…113 In 2013, discernible difference in efficacy and tolerability. 114 Milnacipran has been demonstrated to improve transmission in the descending pain pathways, reducing pain intensity and stiffness and enhancing function. 115 We utilized 50 mg of tramadol, 100 mg of gabapentin every night, 30 mg of duloxetine twice a day, and ketorolac as needed to treat pain in a clinical trial.…”
Section: Discussionmentioning
confidence: 99%
“…113 In 2013, discernible difference in efficacy and tolerability. 114 Milnacipran has been demonstrated to improve transmission in the descending pain pathways, reducing pain intensity and stiffness and enhancing function. 115 We utilized 50 mg of tramadol, 100 mg of gabapentin every night, 30 mg of duloxetine twice a day, and ketorolac as needed to treat pain in a clinical trial.…”
Section: Discussionmentioning
confidence: 99%